Reconstruction Mesh Market Size, Share & Industry Analysis, By Product Type (Urinary Incontinence Reconstruction Mesh, Pelvic Floor Reconstruction Mesh, Hernia Repair Mesh, Breast Reconstruction Mesh), By Gender (Male, Female), By Material (Biological, Non-biological), By End-User (Hospitals & Ambulatory Surgical Centres, Specialty Clinics, Others) and Regional Forecast, 2024-2032

Reconstruction mesh is a type of medical device used for providing additional support and reinfrocement during the repair of damaged tissues. They are extensively used in hernia repair, abdominal wall repair and treatment of stress urinary incontinence. Over the past few years, reconstruction mesh are also being employed in breast reconstruction and chest wall reconstruction. Increasing application of reconstruction mesh is providing a significant boost to the market. In addition to this, introduction of biologically-derived cellular mesh and their rapid adoption is proving impetus to the market.

Increasing prevalence of pelvic organ prolapse, rising number of hernia repair procedures, and rapid adoption of biologically-derived mesh are the key factors driving the market. According to The Office on Women's Health, 3% of the U.S. women population was affected by pelvic organ prolapse in 2016, this is expected to favor the demand for reconstruction mesh. Furthermore, the rising prevalence of female urinary incontinence and breast cancer are expected to fuel the market. Mastectomy is a common procedure for the treatment of breast cancer. Majority of the women undergo breast reconstruction surgery post mastectomy. Increased deployment of reconstructive mesh during the breast reconstruction surgery is anticipated to boost the market during the forecast period.

Key Market Driver -

Rising prevalence of pelvic organ prolapse and urinary incontinence

Key Market Restraint -

Episodes of product recalls

However, episodes of product recalls owing to safety concerns of women and stringent government regulations are the major factors that can hamper the market growth.  In April 2019, the FDA prohibited the selling and distribution of surgical mesh being used for transvaginal repair of pelvic organ prolapse in the U.S., which is expected to negatively impact the market

Market Segmentation:

Globally, the reconstruction mesh market can be segmented on the basis of product type, gender, material, end user, and region. Based on the product, the market can be segmented urinary incontinence reconstruction mesh, hernia repair mesh, pelvic floor reconstruction mesh, breast reconstruction mesh, and others. On the basis of gender, the market can be categorized into male and female. Based on the material, the market can be bifurcated into biological and non-biological. In terms of end-users the market can be segmented into hospitals & ambulatory surgery centres, specialty clinics, and others.

Geographically, the reconstruction mesh market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

Some of the major companies that are present in the reconstruction mesh market are BD, Medtronic, Johnson & Johnson Services Inc., pfm medical ag, B. Braun Melsungen AG, Allergan, Boston Scientific Corporation,  and other prominent players.

Key Insights:

• Number of breast Reconstruction Procedures by Key Countries/Region


• Prevalence of Urinary Incontinence for Key Countries/Region


• Regulatory and Reimbursement Overview by Key Countries/Region


• New Product Launches


• Key Industry Developments Mergers, Acquisitions, and Collaborations

Regional Analysis:

Geographically, the reconstruction mesh market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the market throughout the forecast period owing to the significant increase in the number of breast reconstruction procedures, rising prevalence of urinary incontinence, and new product launches. According to the America Society of Plastic Surgeons, in 2018 a total of 101,657 breast reconstruction procedure were performed in the U.S. This is expected to foster the market in North America. In Europe, the market is poised to surge owing to the significant increase in the number of hernia repair and mastectomy, favorable health reimbursement, and increasing demand for abdominal wall reconstruction. In Asia Pacific, the market is likely to propel owing to the rising prevalence of breast cancer, increasing geriatric population, and rapid adoption of reconstruction matrix. According to the WHO, the incidence of breast cancer in females in Asia is projected to reach 5.4 million by 2030. This is expected to boost the market in Asia Pacific. In the Middle East & Africa and Latin America, the market is anticipated to grow due to rising prevalence of pelvic floor dysfunction, increasing focus on women’s health, and improving healthcare scenario.

To gain extensive insights into the market, Request for Customization

Segmentation

Reconstruction Mesh Market Industry Developments

• In October 2017, Integra Lifesciences Corporation announced the launch of Integra SurgiMend PRS Meshed for breast reconstruction in Europe.


• July 2016, TELA Bio, Inc. announced the launch of OviTex for abdominal wall reconstruction and hernia repair in the U.S.